Voloridge Investment Management
MGNX icon

Voloridge Investment Management’s MacroGenics MGNX Stock Holding History

Voloridge Investment Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-72,879
Closed -$240K – 1294
2024
Q3 		$240K Sell
72,879
-18,448
-20% -$71.9K ﹤0.01% 1121
2024
Q2 		$388K Buy
91,327
+67,412
+282% +$656K ﹤0.01% 1136
2024
Q1 		$352K Buy
+23,915
New +$361K ﹤0.01% 1071
2022
Q2 		– Sell
-105,239
Closed -$927K – 1565
2022
Q1 		$927K Sell
105,239
-12,944
-11% -$143K 0.01% 1148
2021
Q4 		$1.9M Buy
118,183
+69,143
+141% +$1.3M 0.01% 1090
2021
Q3 		$1.03M Buy
+49,040
New +$1.18M 0.01% 1275

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Voloridge Investment Management's MGNX Position: Q4 2024 in Review

Voloridge Investment Management sold out of MacroGenics (MGNX) in Q4 2024, closing a stake of 72,879 shares — an estimated $240K sold.

Voloridge Investment Management first reported a position in MGNX in Q3 2021 and held it in 6 quarters. The position peaked at $1.9M in Q4 2021. 128 funds tracked by Wall St. Rank hold MGNX as of Q4 2024.

  • Voloridge Investment Management reported no remaining MacroGenics position as of Q4 2024 after selling out during the quarter.
  • Voloridge Investment Management sold 72,879 MacroGenics shares in Q4 2024, an estimated $240K.
  • Voloridge Investment Management first reported a position in MacroGenics in Q3 2021 and held it in 6 quarters.
  • Voloridge Investment Management's MacroGenics position peaked at $1.9M in Q4 2021.
  • 128 funds tracked by Wall St. Rank held MacroGenics as of Q4 2024.

Based on Voloridge Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.